XML 160 R142.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED FINANCIAL INFORMATION (PARENT COMPANY ONLY), Condensed Statement of Cash Flows (Details) - USD ($)
$ in Millions
12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:      
Net income $ 818 $ 1,034 $ 857
Adjustments to reconcile net income to net cash provided by operating activities:      
Other 92 51 17
Net change in:      
Accrued compensation and benefits 70 80 132
Net cash provided by operating activities 4,054 577 884
Cash flows from investing activities:      
Net cash used in investing activities (4,985) (1,897) (3,476)
Cash flows from financing activities:      
Purchases of treasury stock (272) (778) (62)
Dividends on common stock (205) (191) (151)
Net cash provided by/(used in) financing activities 4,593 1,373 1,420
Cash and cash equivalents and cash and cash equivalents segregated pursuant to regulations at beginning of year 5,971 5,941 7,146
Cash and cash equivalents and cash and cash equivalents segregated pursuant to regulations at end of year 9,634 5,971 5,941
Cash and cash equivalents 5,390 3,957 3,500
Cash segregated pursuant to regulations 4,244 2,014 2,441
Supplemental disclosures of cash flow information:      
Cash paid for interest 164 283 201
Cash received for income taxes, net 246 390 231
RJF Parent Company      
Cash flows from operating activities:      
Net income 818 1,034 857
Adjustments to reconcile net income to net cash provided by operating activities:      
Loss on investments 4 4 1
Unrealized gain on company-owned life insurance policies, net of expenses (50) (5) (37)
Equity in undistributed net income of subsidiaries (134) (292) (598)
Other 102 100 114
Net change in:      
Assets segregated pursuant to regulations 0 0 (1)
Intercompany receivables 126 (51) 6
Other assets 24 (16) 49
Intercompany payables (70) (22) 88
Other payables 24 (1) 13
Accrued compensation and benefits 73 34 66
Net cash provided by operating activities 917 785 558
Cash flows from investing activities:      
Investments in subsidiaries (106) (24) (205)
(Advances to)/repayments from subsidiaries, net (885) 63 4
Proceeds from sales of investments 9 3 12
Purchase of investments in company-owned life insurance policies, net (55) (44) (70)
Net cash used in investing activities (1,037) (2) (259)
Cash flows from financing activities:      
Proceeds from senior note issuances, net of debt issuance costs paid 494 0 0
Exercise of stock options and employee stock purchases 62 65 63
Purchases of treasury stock (272) (778) (62)
Dividends on common stock (205) (191) (151)
Net cash provided by/(used in) financing activities 79 (904) (150)
Net increase/(decrease) in cash and cash equivalents (41) (121) 149
Cash and cash equivalents and cash and cash equivalents segregated pursuant to regulations at beginning of year 596 717 568
Cash and cash equivalents and cash and cash equivalents segregated pursuant to regulations at end of year 555 596 717
Cash and cash equivalents 478 540 695
Cash segregated pursuant to regulations 77 56 22
Supplemental disclosures of cash flow information:      
Cash paid for interest 72 78 78
Cash received for income taxes, net 32 42 163
Supplemental disclosures of noncash investing activity:      
Investments in subsidiaries, net 0 (43) 0
RJF Credit Facility      
Cash flows from financing activities:      
Proceeds from borrowings on the RJF Credit Facility 0 300 300
Repayment of borrowings on the RJF Credit Facility $ 0 $ (300) $ (300)